Sanna McKinzie

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea‐predominant irritable bowel syndrome

H. J. Kim, Michael Camilleri, Sanna McKinzie et al. · Alimentary Pharmacology & Therapeutics · 2003 · 464 citations · Full text

Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome

Charlene M. Prather, Michael Camilleri, Alan R. Zinsmeister et al. · Gastroenterology · 2000 · 412 citations

Functional Gastrointestinal Disorder, Gastroenterology, Orocecal Transit +4

Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder

Ernest P. Bouras, Michael Camilleri, Duane D. Burton et al. · Gastroenterology · 2001 · 307 citations · Full text

Functional Gastrointestinal Disorder, Medicine, Gastroenterology +6

Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome

Michael Camilleri, Elena Atanasova, Paula J. Carlson et al. · Gastroenterology · 2002 · 280 citations · Full text

Functional Gastrointestinal Disorder, Psychiatry, Medicine +3

Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers

Michael Camilleri, Adil E. Bharucha, Ryuji Ueno et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2006 · 253 citations

Nutrition, Functional Gastrointestinal Disorder, Gastrointestinal Pharmacology +14